A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Wrist Injuries, PRP
In brief
Platelet-rich Plasma (PRP) is formed when a patient's blood sample is concentrated by a commercially available centrifuge. The sample then contains a high concentration of growth factors and has been used for numerous indications in a number of joints. This process has not yet been proven for non-operative management of the Triangular FibroCartilage Complex (TFCC), which is a very commonly injured soft tissue structure in the wrist. This study seeks to determine the efficacy of PRP for TFCC injuries.
Key facts
- Study ID
- NCT03830775
- Run by
- Edna Rath
- People needed
- 0
- Starts
- 2020-10-02
- Expected to finish
- 2023-12-31
- Last updated by the study team
- 2025-09-25
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult patients consenting for wrist injection, who additionally consent to participate in this study.
- MRI which indicates a TFCC tear or Scapho-lunate ligament tear (SL)
You may not qualify if…
- Patients who do not choose to participate in the study or who do not wish to have an injection
- Patients who want an injection - but do not want to be randomized.
- Patients who do not complete one of the follow up documentations.
- Patients who would like to know their injection (unblinded) may be informed but the investigators will still attempt to collect data as per protocol.
Where it is running
- Lola Norton — El Paso, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.